Opus Point Partners Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-25,284	Closed	-$272K	–	66
2019 Q1	$272K	Buy	+25,284	New	+$272K	0.37%	62